Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-08-13
1994-08-23
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514253, 514255, 544362, 544365, 544370, 544372, 544373, 544391, 548542, A61K 31495, C07D295185, C07D40306
Patent
active
053408098
ABSTRACT:
A compound selected from those of formula (I): ##STR1## with R.sub.1, R.sub.2 and n as defined in the description, and medicinal products containing the same useful in treating or in preventing a disorder resulting from cellular damages following upon ischemia, hypoxia, or anoxia.
REFERENCES:
patent: 4997836 (1991-03-01), Sugihara et al.
patent: 5011928 (1991-04-01), Venero et al.
Rault et al, Chemical Abstracts, vol. 117, No. 111468 (1992) (Abstract for EP 486386, May 20, 1992).
Nippon Chemiphar Co, Chemical Abstracts, vol. 99, No. 195003 (1983).
Kimura et al, Chemical Abstracts, vol. 107, No. 198361 (1987).
The Merck Index, tenth edition, 1983, cover page and page 1209 concerning #8254 Scopolamine.
T. W. Robbins, "Neuropsychological evaluation of higher cognitive function in animals and man: can psychopharmacology contribute to neuropsychological theory?", Psychopharmacology, Recent advances and future prospects, (Edited by Susan D. Iversen), pp. 155-169 at p. 165 under heading Cholinergic Contributions to Cognition.
Adam Gerard
Gaudry Michel
Pfeiffer Bruno
Renard Pierre
Renaud de la Faverie Jean-Francois
Adir et Compagnie
Bernhardt Emily
LandOfFree
New 1-(alkoxybenzyl)piperazine amide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New 1-(alkoxybenzyl)piperazine amide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New 1-(alkoxybenzyl)piperazine amide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-503198